Humana Benefits From Rising Premiums Amid High Benefit Ratio
HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.
Centene Sits at 13.25X P/E: Time to Load Up or Look Away for Now?
CNC's low 13.25X P/E may look attractive, but falling margins, heavy debt and shrinking memberships paint a tougher picture.
The Trump administration is changing Covid, childhood vaccine recommendations - here's what it means for you
Several health experts say there are steps Americans can take to navigate the new guidance and try to secure the vaccines they or their children want or need.
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; Elevance Health Inc. ( NYSE: ELV ) ; Fluor Corporation ( NYSE: FLR ) ; and Fly-E Group, Inc. ( NASDAQ: FLYE ) : Grabar Law Office is Investigating Claims on Your Behalf - Cytokinetics ( NASDAQ:CYTK ) , Elevance Health ( NYSE:ELV )
PHILADELPHIA, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. CYTK. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
RFK Jr.'s vaccine panel weakens Covid shot recommendations, calling it an individual decision
The group also voted to emphasize that the Covid vaccine is beneficial for those at high risk of severe illness from the disease.
Top Technology Executives Recognized at the 2025 Carolina CIO ORBIE Awards
RALEIGH, N.C., Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- The 2025 Carolina CIO ORBIE Awards recognized the exceptional leadership and innovation of top technology executives from Lowe's Companies, Inc., Elevance Health, Odyssey Logistics, TIAA, FirstHealth of the Carolinas, Centria Healthcare & ...
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
CVS trims its outlook as Oak Street faces rising medical costs, but new leadership and tech upgrades aim for steady growth.
Zacks Industry Outlook Highlights Cigna and Humana
Cigna and Humana stand out in the HMO space, leveraging growth platforms and Medicare demand despite cost and regulatory pressures.
2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs
The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.
Covid shot access, coverage at stake as RFK Jr.'s hand-picked vaccine panel convenes
Some experts warn that weakening recommendations for Covid vaccines and other shots could make it harder for some people to access jabs and have them covered.
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. ( NASDAQ: APLT ) ; DoubleVerify Holdings, Inc. ( NYSE: DV ) ; Elevance Health Inc. ( NYSE: ELV ) ; and V.F. Corp. ( NYSE: VFC ) : Grabar Law Office is Investigating Claims on Your Behalf - DoubleVerify Holdings ( NYSE:DV ) , Applied Therapeutics ( NASDAQ:APLT )
PHILADELPHIA, Sept. 17, 2025 ( GLOBE NEWSWIRE ) -- Applied Therapeutics, Inc. APLT - Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics.
Decoding Elevance Health's Options Activity: What's the Big Picture? - Elevance Health ( NYSE:ELV )
Financial giants have made a conspicuous bullish move on Elevance Health. Our analysis of options history for Elevance Health ELV revealed 9 unusual trades. Delving into the details, we found 33% of traders were bullish, while 33% showed bearish tendencies.
Arista Networks and Elevance Health have been highlighted as Zacks Bull and Bear of the Day
Arista Networks shines with soaring sales and earnings beats, while Elevance Health cuts guidance and struggles in 2025.
Bear of the Day: Elevance Health ( ELV )
Lowered guidance has been a driving force behind the poor share performance, with EPS revisions remaining bearish.
New Strong Sell Stocks for September 15th
CE, ELV and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2025.
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.
New Strong Sell Stocks for September 11th
REFI, ELV and TAP have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2025.
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. ( NASDAQ: APLT ) ; Elevance Health Inc. ( NYSE: ELV ) ; LifeMD, Inc. ( NASDAQ: LFMD ) ; and Quantum Corporation ( NASDAQ: QMCO ) : Grabar Law Office is Investigating Claims on Your Behalf - Applied Therapeutics ( NASDAQ:APLT ) , Elevance Health ( NYSE:ELV )
PHILADELPHIA, Sept. 10, 2025 ( GLOBE NEWSWIRE ) -- Applied Therapeutics APLT - Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc.
ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Elevance Health ( NYSE:ELV )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance ( ELV ) To Contact Him Directly To Discuss Their Options
Elevance Health's Options: A Look at What the Big Money is Thinking - Elevance Health ( NYSE:ELV )
Investors with a lot of money to spend have taken a bullish stance on Elevance Health ELV. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
UnitedHealth & AI: Can Technology Redefine Healthcare Efficiency?
UNH is leveraging AI to streamline insurance and care delivery, aiming to boost efficiency and improve patient outcomes.
What's Driving the Market Sentiment Around Elevance Health? - Elevance Health ( NYSE:ELV )
Elevance Health's ELV short percent of float has risen 11.11% since its last report. The company recently reported that it has 3.16 million shares sold short, which is 1.4% of all regular shares that are available for trading.
Cyberattack Hangover: Senators Question UnitedHealth's Loan Playbook
Senators question UNH over tough loan repayment demands post-cyberattack, adding to regulatory and cost pressures.
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure
CVS' Health Care Benefit arm shines in Q2, driven by government plans, even as ACA exit and utilization pressures weigh.
Is ELV's Push Beyond Insurance a Blueprint for the Healthcare Future?
Elevance Health expands beyond insurance into primary care, digital health and pharmacy services, aiming to reshape healthcare delivery.
Not Just Medicare, UnitedHealth's Optum Rx Gets Its Own DOJ Checkup
UNH faces a widened DOJ probe, covering Optum Rx and physician payments, as rising medical costs pressure its business.
CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?
CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.
UnitedHealth's Misdiagnosis: Can Berkshire's Bet Spark a Recovery?
Berkshire's $1.57B bet on UNH sparks investor interest, but soaring costs, weak earnings and legal woes still cloud recovery hopes.
UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?
UNH expands behavioral health with Optum's digital tools, partnerships and integrated care to tap rising demand.
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
UnitedHealth's Expansion Into ASCs: Redefining the Operating Room
UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?
Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.
UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?
UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.
Danaher ( DHR ) Up 6.8% Since Last Earnings Report: Can It Continue?
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth's Push Into Home Health: A New Growth Chapter?
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
Food as Medicine: Elevance Health & NACHC Integrate Nutrition in Care
ELV partners with NACHC to bring Food as Medicine into primary care, targeting nutritional insecurities and chronic disease.
Buffett's Shot in the Arm Sends UnitedHealth Soaring Against the Odds
Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.
Why I Bought the Dip in UnitedHealth Group
This top health insurer scans as a downright bargain at current levels.
Oncology Institute TOI Earnings Call Transcript
Image source: The Motley Fool.Aug. 13, 2025 at 5 p.m. ETChief Executive Officer - Daniel VirnichContinue reading ...
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion
ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.
Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline
ELV's 20% YTD slump reflects shrinking memberships, rising costs and deepening analyst pessimism despite long-term growth levers.
Sera Prognostics ( SERA ) Q2 Loss Down 4%
Sera Prognostics ( NASDAQ:SERA ) , a diagnostic company specializing in pregnancy risk prediction, reported Q2 2025 results on August 6, 2025. The company's headline news was a net loss improvement and continued strategic investment toward commercial rollout, despite revenue remaining extremely ...
Elevance Health's Options: A Look at What the Big Money is Thinking - Elevance Health ( NYSE:ELV )
Investors with a lot of money to spend have taken a bullish stance on Elevance Health ELV. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.
Meta Platforms and Elevance Health have been highlighted as Zacks Bull and Bear of the Day
Meta earns Bull of the Day honors after a robust quarter, while Elevance Health tumbles on weak results and a steep EPS cut.
Bear of the Day: Elevance Health ( ELV )
A big guidance cut paints a challenging picture for the company's shares in the near term.
Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?
CI's Q2 results are likely to hinge on Evernorth's growth as core healthcare revenues and premiums face steep declines.
